Studies characterizing patients with PIK3CA-mutated CRC have suggested that tumors exhibiting these mutations are more likely to be located in the proximal colon [77, 80, 84], and to exhibit KRAS mutations [75–80, 84] than PIK3CA-wildtype colorectal tumors. The gene discussed is PIK3CA; the disease is colorectal neoplasm.